ロード中...
Phase 1b dose-finding study of motesanib with docetaxel or paclitaxel in patients with metastatic breast cancer
The purpose of this study was to investigate the safety, tolerability, and pharmacokinetics of motesanib when combined with docetaxel or paclitaxel in patients with metastatic breast cancer. In this open-label, dose-finding, phase 1b study, patients received motesanib 50 or 125-mg orally once daily...
保存先:
| 主要な著者: | , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3413817/ https://ncbi.nlm.nih.gov/pubmed/22872523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-012-2135-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|